Illegal Rapamune Marketing Leads to $491M Whistleblower Settlement
Pfizer pays $491M to settle charges that Wyeth illegally marketed the immunosuppressant Rapamune.
Tag Archives: Rapamune
-
-
DOJ to Intervene in Rapamune Whistleblower Lawsuit Against Pfizer
The federal government and a number of states have decided to intervene in a whistleblower lawsuit that accuses Pfizer’s Wyeth unit of giving kickbacks to doctors to encourage them to…
-
Pfizer Faces Criminal Investigation Over Rapamune Marketing
Federal prosecutors have opened a criminal investigation into Wyeth’s promotions and marketing activities involving the organ transplant drug Rapamune.
-
Kidney Transplant Drugs Receive New Warnings About Infection Side Effects
The FDA is requiring new warnings on several immunosuppressant drugs designed to prevent renal transplant patients from rejecting new kidneys. The new labeling will warn users of potential side effects…
-
Rapamune Side Effects May Increase Risk of Death After Liver Transplant: FDA
The FDA has issued a warning to transplant doctors that switching their patients to the anti-organ transplant rejection drug Rapamune after a liver transplant may increase the risk of death.
-
Rapamune (sirolimus) Lawsuits
Recent research suggests that Rapamune, also known as sirolimus, may increase the risk of diabetes after a kidney transplant. This is a serious health concern, and could lead to kidney…
